Prediagnostic Vitamin D Status and Colorectal Cancer Survival by Vitamin D Binding Protein Isoforms in US Cohorts
- PMID: 36550068
- PMCID: PMC10188303
- DOI: 10.1210/clinem/dgac742
Prediagnostic Vitamin D Status and Colorectal Cancer Survival by Vitamin D Binding Protein Isoforms in US Cohorts
Abstract
Context: Lower 25-hydroxyvitamin D (25(OH)D) levels have consistently been associated with higher mortality among participants with colorectal cancer (CRC).
Objective: To investigate whether the association between 25(OH)D and CRC mortality differs according to vitamin D binding protein (also known as Gc) isoforms.
Methods: We examined the association between prediagnostic 25(OH)D levels and overall and CRC-specific mortality among participants with CRC within 2 prospective US cohorts. Cox proportional hazards regression was used to estimate the hazard ratios (HRs) and 95% CIs.
Results: 588 participants with CRC were observed until the date of death or last follow-up (2018), whichever came first. Deficient vs sufficient 25(OH)D concentrations (<30 vs ≥50 nmol/L) were associated with higher overall mortality (HR 2.06; 95% CI 1.34-3.18) but not with CRC-specific mortality (HR 1.51; 95% CI 0.75-3.07). The HRs for overall mortality comparing deficient vs sufficient concentrations were 2.43 (95% CI 1.26-4.70) for those with the Gc1-1 isoform (rs4588 CC) and 1.63 (95% CI 0.88-3.02) for those with the Gc1-2 or Gc2-2 (rs4588 CA or AA) isoform (P for interaction = .54). The HRs for CRC-specific mortality were 1.18 (95% CI 0.27-5.14) for those with the Gc1-1 isoform and 1.41 (95% CI 0.62-3.24) for those with the Gc1-2 or Gc2-2 isoform (P for interaction = .94).
Conclusion: In these 2 US cohorts, we found that lower 25(OH)D levels were associated with higher overall mortality, but this association did not differ by Gc isoforms.
Keywords: Gc2 isoform; cancer survival; colorectal cancer survival; vitamin D; vitamin D binding protein.
© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
Similar articles
-
Vitamin D binding protein genetic isoforms, serum vitamin D, and cancer risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.PLoS One. 2024 Dec 20;19(12):e0315252. doi: 10.1371/journal.pone.0315252. eCollection 2024. PLoS One. 2024. PMID: 39705237 Free PMC article.
-
Association of prediagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms.Int J Cancer. 2020 Nov 15;147(10):2725-2734. doi: 10.1002/ijc.33043. Epub 2020 May 25. Int J Cancer. 2020. PMID: 32391587 Free PMC article.
-
Prediagnostic Serum Vitamin D, Vitamin D Binding Protein Isoforms, and Cancer Survival.JNCI Cancer Spectr. 2022 Mar 2;6(2):pkac019. doi: 10.1093/jncics/pkac019. JNCI Cancer Spectr. 2022. PMID: 35603848 Free PMC article.
-
Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis.Clin Nutr. 2020 Aug;39(8):2525-2538. doi: 10.1016/j.clnu.2019.11.012. Epub 2019 Nov 16. Clin Nutr. 2020. PMID: 31784301
-
Could vitamin D sufficiency improve the survival of colorectal cancer patients?J Steroid Biochem Mol Biol. 2015 Apr;148:239-44. doi: 10.1016/j.jsbmb.2014.12.010. Epub 2014 Dec 19. J Steroid Biochem Mol Biol. 2015. PMID: 25533386 Review.
Cited by
-
Vitamin D's Impact on Cancer Incidence and Mortality: A Systematic Review.Nutrients. 2025 Jul 16;17(14):2333. doi: 10.3390/nu17142333. Nutrients. 2025. PMID: 40732958 Free PMC article. Review.
-
SIRT1 Mediates the Antagonism of Wnt/β-Catenin Pathway by Vitamin D in Colon Carcinoma Cells.Int J Biol Sci. 2024 Oct 7;20(14):5495-5509. doi: 10.7150/ijbs.95875. eCollection 2024. Int J Biol Sci. 2024. PMID: 39494323 Free PMC article.
-
Association of serum 25-hydroxy-vitamin D concentration and risk of mortality in cancer survivors in the United States.BMC Cancer. 2024 Apr 30;24(1):545. doi: 10.1186/s12885-024-12304-8. BMC Cancer. 2024. PMID: 38689243 Free PMC article.
-
Vitamin D binding protein genetic isoforms, serum vitamin D, and cancer risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.PLoS One. 2024 Dec 20;19(12):e0315252. doi: 10.1371/journal.pone.0315252. eCollection 2024. PLoS One. 2024. PMID: 39705237 Free PMC article.
-
Vitamin D binding protein correlate with estrogen increase after administration of human chorionic gonadotropin but do not affect ovulation, embryo, or pregnancy outcomes.Front Endocrinol (Lausanne). 2024 May 23;15:1401975. doi: 10.3389/fendo.2024.1401975. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38846489 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, et al. . Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209‐249. - PubMed
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7‐33. - PubMed
-
- Feskanich D, Ma J, Fuchs CS, et al. . Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13(9):1502‐1508. - PubMed
-
- Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst. 2007;99(14):1120‐1129. - PubMed
-
- Wactawski-Wende J, Kotchen JM, Anderson GL, et al. . Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354(7):684‐696. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous